Who are Intraduodenal quinine hydrochloride's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Intraduodenal denatonium benzoate, Intragastric denatonium benzoate.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/intraduodenal-quinine-hydrochloride.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Intraduodenal quinine hydrochloride — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Intraduodenal quinine hydrochloride (Intraduodenal quinine hydrochloride) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Bitter taste receptor agonist. Area: Diabetes.

marketed Bitter taste receptor agonist TAS2R (bitter taste receptors) Diabetes Small molecule Live · refreshed every 30 min

Target snapshot

Intraduodenal quinine hydrochloride (Intraduodenal quinine hydrochloride) — Universitaire Ziekenhuizen KU Leuven. Intraduodenal quinine hydrochloride acts as a bitter taste receptor agonist that stimulates local sensory pathways in the small intestine to modulate glucose homeostasis and metabolic function.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Intraduodenal quinine hydrochloride TARGET	Intraduodenal quinine hydrochloride	Universitaire Ziekenhuizen KU Leuven	marketed	Bitter taste receptor agonist	TAS2R (bitter taste receptors)
Intraduodenal denatonium benzoate	Intraduodenal denatonium benzoate	Universitaire Ziekenhuizen KU Leuven	marketed	Bitter taste receptor agonist	Bitter taste receptors (T2Rs), particularly TAS2R family members
Intragastric denatonium benzoate	Intragastric denatonium benzoate	Universitaire Ziekenhuizen KU Leuven	marketed	Bitter taste receptor agonist / Aversive agent	Bitter taste receptors (T2R family)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Bitter taste receptor agonist class)

Universitaire Ziekenhuizen KU Leuven · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Intraduodenal quinine hydrochloride — Competitive Intelligence Brief. https://druglandscape.com/ci/intraduodenal-quinine-hydrochloride. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab